Raymond James & Associates »

Atara Biotherapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $14k 20k 0.69
2023-12-31 $10k 20k 0.51
2023-09-30 $281k 190k 1.48
2023-06-30 $302k 187k 1.61
2023-03-31 $548k 189k 2.90
2022-12-31 $596k 182k 3.28
2022-09-30 $697k 184k 3.78
2022-06-30 $508k 65k 7.79
2020-03-31 $202k 24k 8.50
2019-12-31 $349k 21k 16.49
2019-09-30 $286k 20k 14.13
2019-06-30 $411k 21k 20.09
2019-03-31 $1.0M 26k 39.75
2018-12-31 $893k 26k 34.73
2018-09-30 $1.1M 26k 41.34
2018-06-30 $970k 26k 36.74
2018-03-31 $1.1M 28k 38.99
2017-12-31 $458k 25k 18.08
2017-09-30 $391k 24k 16.56
2017-06-30 $330k 24k 13.99
2017-03-31 $417k 20k 20.54
2016-12-31 $256k 18k 14.21